Tech Company Financing Transactions
MacuLogix Funding Round
MacuLogix closed a $38.7 million Series D financing round on 3/5/2019. Backers included Vivo Capital, Berwind Private Equity and Fisk Ventures.
Transaction Overview
Company Name
Announced On
3/5/2019
Transaction Type
Venture Equity
Amount
$38,700,000
Round
Series D
Investors
Vivo Capital (Lead Investor) (Jack Nielsen)
Proceeds Purpose
This funding will be used to further expand the MacuLogix team and company infrastructure to support the growing sales and practice integration efforts of the AdaptDx automated dark adaptometer, both domestically and internationally.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
3721 TecPort Dr. 301
Harrisburg, PA 17111
USA
Harrisburg, PA 17111
USA
Phone
Website
Email Address
Overview
MacuLogix has developed a diagnostic for earlydetection of age-related macular degeneration (AMD).
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
William McPhee
Chief Technical Officer
Gregory Jackson
VP - Customer Service
Jennifer DelPrete
VP - Finance
Daniel Dorsey
VP - Marketing
David Miller
VP - Sales
Armond Dantino
Browse more venture capital transactions:
Prev: 3/5/2019: Jupiter Intelligence venture capital transaction
Next: 3/5/2019: VOI Technology venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs